- Export Intent
Licensed Rwandan cannabis producer intends to export medical cannabis. Rwanda's program is export-oriented — EU-GMP certification is the standard for export-eligible products.
- Rwanda FDA cultivation and/or manufacturing license
- GACP + EU-GMP certification
- Destination country import authorization
- Producer Holds License
Producer must hold a valid Rwanda FDA cultivation and/or manufacturing license with GACP and EU-GMP certification. EU-GMP is required for pharmaceutical-grade export.
- Valid Rwanda FDA license
- GACP certification (current)
- EU-GMP certification for export-grade product
- EU QP engagement for batch certification
- Obtain Destination Import Auth
Destination country import authorization must be obtained before Rwanda FDA will issue export authorization. EU member states, UK, and others require their own import permits.
- Germany: BfArM BtMG §3 import authorization
- UK: Home Office DLCU license
- Australia: TGA + ODC import permits
- Import auth must name the Rwandan exporter
- Rwanda FDA Export Authorization
Apply to Rwanda FDA for per-shipment export authorization. Submit destination import authorization with application.
- Destination import authorization (copy)
- Product specifications, batch numbers, quantity
- GACP and EU-GMP certificates (current)
- QP batch certification
- Processing: approximately 2–4 weeks
- Kigali Airport Export
Primary export point — Kigali International Airport (KGL). Rwandan customs export declaration. Cold chain logistics for pharmaceutical-grade product.
- Rwanda FDA export authorization (original)
- All GMP/GACP certificates
- COA per batch
- Rwandan customs export declaration
- INCB export notification
- Export Cleared ✓
Rwandan medical cannabis exported to international markets. Rwanda's strategic positioning as African export hub: favorable climate, government support, EU-GMP-aligned standards.